This report is an essential reference for who looks for detailed information on North America Over the Counter (OTC) Drugs & Dietary Supplements market. The report covers data on North America markets including historical and future trends for supply, market size, prices, trading,
The global OTC drugs market is estimated to garner a revenue of ~ USD 294 billion by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More info:- https://www.imarcgroup.com/over-the-counter-drugs-market
According to the latest research report by IMARC Group, The United States over the counter (OTC) drugs market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.45% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-over-the-counter-drugs-market
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. Analysts forecast the global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-gastrointestinal-otc-drugs-2015-2019-market
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
This report studies the Global Gastrointestinal OTC Drugs market status and forecast, categorizes the global Gastrointestinal OTC Drugs market size (value & volume) by manufacturers, type, application, and region.
Big Market Research “OTC Drugs Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/otc-drugs-in-china-market China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Global Over the Counter OTC Drugs & Dietary Supplements market competition by top manufacturers, with production, price, revenue value and market share for each manufacturer; the top players including Pfizer Novartis International Roche Holding Merck Sanofi Johnson & Johnson
Big Market Research present “OTC Pharmaceuticals Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2018. Visit for more info @ http://www.bigmarketresearch.com/otc-pharmaceuticals-in-latin-america-2014-2018-market The OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs.
The dermatology OTC medications market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028. https://www.theinsightpartners.com/reports/dermatology-otc-medications-market
The global acne drugs market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 7.4% during 2022-2027 More info: https://www.imarcgroup.com/acne-drugs-market
North America was the largest region in the dermatology drugs market in 2017, accounting for around 31% market share. The USA was the largest country in the market in 2017, accounting for over 24% market share. Read Report https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report-2018
The Business Research Company has recently published a new market report on Pharmaceuticals Market provides a comprehensive analysis, incisive insights, present and future growth prospects. https://bit.ly/2zTqBdK
Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death.
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
The webinar will offer an overview of FDA requirements for marketing, labelling and promotion of OTC drugs in the U.S. It will cover how OTC pharmacy can be effectively marketed and the OTC Monographs and their importance to compliance in general and drug labels in particular. Challenges of marketing OTC drugs in the U.S. will be covered.
The major players in the global analgesics market are Smith & Nephew, Stryker, Zimmer Biomet, B. Braun Melsungen and Wright Medical Group...@ @ https://bit.ly/36ZueMm
Major players in the Antidiarrhoeals Market are GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals. Read More @ https://bit.ly/3nwZD0i
Analgesics Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
Drugs for Lipid Metabolism Disease, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
After conducting a thorough research on the historical as well as current growth parameters of the Vaginitis Treatment Drugs Market, growth prospects are obtained with maximum precision.
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
The report titled Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory) provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers and restraints.
Bharat Book Bureau provides the report, on “Opportunity in The Indian OTC Drug Market - 2015” This report Market data and analytics are derived from a combination of primary and secondary sources. https://www.bharatbook.com/drugs-market-research-reports-643132/opportunity-indian-otc-drug.html
Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.
The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Read Complete Report @ http://www.researchbeam.com/anti-inflammatory-therapeutics-market On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Enquire @ http://www.researchbeam.com/anti-inflammatory-therapeutics-market/enquire-about-report
The global In-vitro diagnostics (IVD) market is estimated to reach USD 80 Billion, in 2024. In 2014, India holds total 1% market share of global IVD market. To get more details read our report: https://bit.ly/2fD38Do
OTC Drug Product Pharmacovigilance Timothy R. Dring Johnson & Johnson Pharmaceutical R&D Overview I. Introduction II. Regulatory Status A. NDA'ed drugs B. Monograph ...
The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Get more details at: http://www.apacmarket.com/top-market/anti-inflammatory-therapeutics-market
Big Market Research adds a report “Global Antibacterial Drugs Market- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2019" Get Complete Report @ http://www.bigmarketresearch.com/global-antibacterial-drugs-2015-2019-market Antibacterial Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global antibacterial drugs market and its growth prospects in the coming years. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/355940
Manufacturers operating in the global cold, cough and sore throat remedies market are likely to target emerging economies through mergers with established local players to increase their customer base. While considering the overall market approach the analysts of Future Market Insights have observed that key players are focussing on the need to efficiently meet requirements of various dosage types, by ensuring best combination products to effectively treat cold, cough and sore throat, and Rx to OTC switch so that products can be easily available to customers. In a new report titled “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment 2016–2026,” we have observed that strengthening of supply chain particularly in regions such as Asia Pacific excluding Japan and the Middle East and Africa are key focus areas for players in this market.
Both physicians and pharmacists face a high level of scrutiny from the Drug ... Mr. Falcone has been CFO of Netgrocer.com and Bed, Bath and Beyond. ...
Street Drugs Part 4: Prescription for Trouble. Robert S. Cole. Paramedic, ... We will focus on some of the particular problems with prescription and OTC drugs ...
In the vibrant realm of healthcare, the Indian Pharmaceutical Market shines as a key player, poised to register a remarkable CAGR of 10.7% during the forecast period (2020-2025).
According to the latest research report by IMARC Group, The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032. More Info:- https://www.imarcgroup.com/xerostomia-therapeutics-market
The Acne Treatment Market research of 65 pages with 31 Figures and 11 Tables to the pharmaceuticals industry segment of its online data and intelligence library. The global acne market represents a small fraction of total dermatology market and both over the counter drugs and prescription drugs are used to treat acne. Purchase this report at http://www.marketreportsonline.com/contacts/purchase.php?name=396023.
Street Drugs Part 4: Prescription for Trouble Robert S. Cole Paramedic, CCEMT-P Overview We will review some common principles of caring for the Pharmacologically ...
According to the latest research report by IMARC Group, The global FMCG packaging market size reached US$ 761.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,126.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.25% during 2024-2032. More Info:- https://www.imarcgroup.com/fmcg-packaging-market
Big Market Research “Global Opioid-Induced Constipation Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-opioid-induced-constipation-2015-2019-market Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents.
Veterinary health products, including veterinary pharmaceuticals, biologicals and medicated feed additives (MFAs), have transformed the health and welfare of livestock and companion animals worldwide. For More Details: http://goo.gl/C69Cwk
The global anal fissure treatment market is estimated to garner considerable revenue by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031.
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026.
Analgesics Market Is Expected to Reach $26.4 Billion, Globally, by 2022. Visit at: https://www.alliedmarketresearch.com/analgesics-market A new report published by Allied Market Research titled, “World Analgesics Market - Opportunities and Forecasts, 2015 - 2022” projects that the world analgesics market would reach $26.4 billion by 2022. The non-opioids segment would continue to be the highest revenue-generating segment throughout the forecast period. North America and Europe, are likely to continue their lead through 2022; they collectively accounted for over half of the overall market share in the global analgesics market in 2015.